BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:09 PM
Aug 03, 2009
 |  BC Extra  |  Clinical News

Repros suspends Proellex trials

Repros Therapeutics Inc. (NASDAQ:RPRX) suspended dosing in clinical trials of Proellex because of clinically significant increases in liver enzymes associated with the 25 and 50 mg doses. The oral selective

Read the full 143 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >